Altimmune (ALT) Times Interest Earned (2010 - 2026)
Altimmune's (ALT) quarterly Times Interest Earned came in at -$9.04 in Q1 2026, down 3.68% year-on-year from -$9.38 in Q1 2025, and up 73.73% on a QoQ basis from -$34.4 in Q4 2025.
Altimmune (ALT) Times Interest Earned (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Times Interest Earned data on file, last reported at -$9.04 in Q1 2026.
- On a quarterly basis, Times Interest Earned fell 3.68% year-over-year to -$9.04 in Q1 2026; TTM through Mar 2026 was -$36.12, a 7.92% increase from a year earlier, with the FY2025 full-year figure at -$32.57, down 3259.75% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$9.04, up from -$34.4 in the prior quarter.
- Over the last five years, Times Interest Earned for ALT reached as high as $92.12 in Q4 2023 and fell as low as -$386.75 in Q3 2022.
- Historically, Times Interest Earned has averaged -$72.06 across 5 years, with a median of -$14.28 in 2025.
- Across the five-year window, Times Interest Earned sank 21748.56% in 2022 and soared 99.18% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at $58.91 in 2022, then surged by 56.36% to $92.12 in 2023, then sank by 154.87% to -$50.54 in 2024, then jumped by 31.94% to -$34.4 in 2025, then surged by 73.73% to -$9.04 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$9.04 in Q1 2026, -$34.4 in Q4 2025, and -$13.98 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | -9.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.04 |
| Dec 31, 2025 | -34.40 |
| Sep 30, 2025 | -13.98 |
| Jun 30, 2025 | -14.28 |
| Mar 31, 2025 | -8.72 |
| Dec 31, 2024 | -50.54 |
| Sep 30, 2024 | -5.95 |
| Jun 30, 2024 | -5.14 |
| Mar 31, 2024 | -1.78 |
| Dec 31, 2023 | 92.12 |
| Sep 30, 2023 | -94.31 |
| Jun 30, 2023 | -24.80 |
| Mar 31, 2023 | -217.59 |
| Dec 31, 2022 | 58.91 |
| Sep 30, 2022 | -386.75 |
| Jun 30, 2022 | -313.77 |
| Mar 31, 2022 | -194.99 |
| Dec 31, 2021 | 386.85 |
| Sep 30, 2021 | -2.37 |
| Jun 30, 2021 | -1.45 |